<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2020-10-07" version="187">
<accession>P54259</accession>
<accession>Q99495</accession>
<accession>Q99621</accession>
<accession>Q9UEK7</accession>
<name>ATN1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Atrophin-1</fullName>
</recommendedName>
<alternativeName>
<fullName>Dentatorubral-pallidoluysian atrophy protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">ATN1</name>
<name type="synonym">D12S755E</name>
<name type="synonym">DRPLA</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Nat. Genet." volume="8" first="177" last="182">
<title>Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA).</title>
<authorList>
<person name="Nagafuchi S."/>
<person name="Yanagisawa H."/>
<person name="Ohsaki E."/>
<person name="Shirayama T."/>
<person name="Tadokoro K."/>
<person name="Inoue T."/>
<person name="Yamada M."/>
</authorList>
<dbReference type="PubMed" id="7842016"/>
<dbReference type="DOI" id="10.1038/ng1094-177"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT 484-GLN--GLN-488 DEL</scope>
<scope>INVOLVEMENT IN DRPLA</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="Am. J. Hum. Genet." volume="57" first="1050" last="1060">
<title>Molecular cloning of a full-length cDNA for dentatorubral-pallidoluysian atrophy and regional expressions of the expanded alleles in the CNS.</title>
<authorList>
<person name="Onodera O."/>
<person name="Oyake M."/>
<person name="Takano H."/>
<person name="Ikeuchi T."/>
<person name="Igarashi S."/>
<person name="Tsuji S."/>
</authorList>
<dbReference type="PubMed" id="7485154"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT 484-GLN--GLN-488 DEL</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="Brain Res. Mol. Brain Res." volume="36" first="219" last="226">
<title>DRPLA gene (atrophin-1) sequence and mRNA expression in human brain.</title>
<authorList>
<person name="Margolis R.L."/>
<person name="Li S.-H."/>
<person name="Young W.S."/>
<person name="Wagster M.V."/>
<person name="Stine O.C."/>
<person name="Kidwai A.S."/>
<person name="Ashworth R.G."/>
<person name="Ross C.A."/>
</authorList>
<dbReference type="PubMed" id="8965642"/>
<dbReference type="DOI" id="10.1016/0169-328x(95)00241-j"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANTS ILE-339 AND 484-GLN--GLN-488 DEL</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1997" name="Genome Res." volume="7" first="268" last="280">
<title>Large-scale sequencing in human chromosome 12p13: experimental and computational gene structure determination.</title>
<authorList>
<person name="Ansari-Lari M.A."/>
<person name="Shen Y."/>
<person name="Muzny D.M."/>
<person name="Lee W."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="9074930"/>
<dbReference type="DOI" id="10.1101/gr.7.3.268"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>POLYMORPHISM OF POLY-GLN REGION</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1996" name="Hum. Mol. Genet." volume="5" first="373" last="379">
<title>A unique origin and multistep process for the generation of expanded DRPLA triplet repeats.</title>
<authorList>
<person name="Yanagisawa H."/>
<person name="Fujii K."/>
<person name="Nagafuchi S."/>
<person name="Nakahori Y."/>
<person name="Nakagome Y."/>
<person name="Akane A."/>
<person name="Nakamura M."/>
<person name="Sano A."/>
<person name="Komure O."/>
<person name="Kondo I."/>
<person name="Jin D.K."/>
<person name="Soerensen S.A."/>
<person name="Potter N.T."/>
<person name="Young S.R."/>
<person name="Nakamura K."/>
<person name="Nukina N."/>
<person name="Nagao Y."/>
<person name="Tadokoro K."/>
<person name="Okuyama T."/>
<person name="Miyashita T."/>
<person name="Inoue T."/>
<person name="Kanazawa I."/>
<person name="Yamada M."/>
</authorList>
<dbReference type="PubMed" id="8852663"/>
<dbReference type="DOI" id="10.1093/hmg/5.3.373"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-76</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1994" name="Nat. Genet." volume="6" first="9" last="13">
<title>Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA).</title>
<authorList>
<person name="Koide R."/>
<person name="Ikeuchi T."/>
<person name="Onodera O."/>
<person name="Tanaka H."/>
<person name="Igarashi S."/>
<person name="Endo K."/>
<person name="Takahashi H."/>
<person name="Kondo R."/>
<person name="Ishikawa A."/>
<person name="Hayashi T."/>
</authorList>
<dbReference type="PubMed" id="8136840"/>
<dbReference type="DOI" id="10.1038/ng0194-9"/>
</citation>
<scope>INVOLVEMENT IN DRPLA</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1994" name="Nat. Genet." volume="7" first="521" last="524">
<title>The Haw River syndrome: dentatorubropallidoluysian atrophy (DRPLA) in an African-American family.</title>
<authorList>
<person name="Burke J.R."/>
<person name="Wingfield M.S."/>
<person name="Lewis K.E."/>
<person name="Roses A.D."/>
<person name="Lee J.E."/>
<person name="Hulette C."/>
<person name="Pericak-Vance M.A."/>
<person name="Vance J.M."/>
</authorList>
<dbReference type="PubMed" id="7951323"/>
<dbReference type="DOI" id="10.1038/ng0894-521"/>
</citation>
<scope>INVOLVEMENT IN HRS</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="29238" last="29242">
<title>Dentatorubral pallidoluysian atrophy (DRPLA) protein is cleaved by caspase-3 during apoptosis.</title>
<authorList>
<person name="Miyashita T."/>
<person name="Okamura-Oho Y."/>
<person name="Mito Y."/>
<person name="Nagafuchi S."/>
<person name="Yamada M."/>
</authorList>
<dbReference type="PubMed" id="9361003"/>
<dbReference type="DOI" id="10.1074/jbc.272.46.29238"/>
</citation>
<scope>PROTEOLYTIC CLEAVAGE BY CASP-3 AT ASP-109</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1998" name="Mol. Cell. Neurosci." volume="11" first="149" last="160">
<title>Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins.</title>
<authorList>
<person name="Wood J.D."/>
<person name="Yuan J."/>
<person name="Margolis R.L."/>
<person name="Colomer V."/>
<person name="Duan K."/>
<person name="Kushi J."/>
<person name="Kaminsky Z."/>
<person name="Kleiderlein J.J. Jr."/>
<person name="Sharp A.H."/>
<person name="Ross C.A."/>
</authorList>
<dbReference type="PubMed" id="9647693"/>
<dbReference type="DOI" id="10.1006/mcne.1998.0677"/>
</citation>
<scope>INTERACTION WITH WWP1; WWP2 AND WWP3</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="Hum. Mol. Genet." volume="8" first="947" last="957">
<title>Dentatorubral-pallidoluysian atrophy protein interacts through a proline-rich region near polyglutamine with the SH3 domain of an insulin receptor tyrosine kinase substrate.</title>
<authorList>
<person name="Okamura-Oho Y."/>
<person name="Miyashita T."/>
<person name="Ohmi K."/>
<person name="Yamada M."/>
</authorList>
<dbReference type="PubMed" id="10332026"/>
<dbReference type="DOI" id="10.1093/hmg/8.6.947"/>
</citation>
<scope>INTERACTION WITH BAIAP2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="8730" last="8736">
<title>Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity.</title>
<authorList>
<person name="Ellerby L.M."/>
<person name="Andrusiak R.L."/>
<person name="Wellington C.L."/>
<person name="Hackam A.S."/>
<person name="Propp S.S."/>
<person name="Wood J.D."/>
<person name="Sharp A.H."/>
<person name="Margolis R.L."/>
<person name="Ross C.A."/>
<person name="Salvesen G.S."/>
<person name="Hayden M.R."/>
<person name="Bredesen D.E."/>
</authorList>
<dbReference type="PubMed" id="10085113"/>
<dbReference type="DOI" id="10.1074/jbc.274.13.8730"/>
</citation>
<scope>PROTEOLYTIC CLEAVAGE AT ASP-109</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ASP-109</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="Hum. Mol. Genet." volume="9" first="1433" last="1442">
<title>Protein binding of a DRPLA family through arginine-glutamic acid dipeptide repeats is enhanced by extended polyglutamine.</title>
<authorList>
<person name="Yanagisawa H."/>
<person name="Bundo M."/>
<person name="Miyashita T."/>
<person name="Okamura-Oho Y."/>
<person name="Tadokoro K."/>
<person name="Tokunaga K."/>
<person name="Yamada M."/>
</authorList>
<dbReference type="PubMed" id="10814707"/>
<dbReference type="DOI" id="10.1093/hmg/9.9.1433"/>
</citation>
<scope>INTERACTION WITH RERE</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="J. Cell Biol." volume="150" first="939" last="948">
<title>Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene product, interacts with ETO/MTG8 in the nuclear matrix and represses transcription.</title>
<authorList>
<person name="Wood J.D."/>
<person name="Nucifora F.C. Jr."/>
<person name="Duan K."/>
<person name="Zhang C."/>
<person name="Wang J."/>
<person name="Kim Y."/>
<person name="Schilling G."/>
<person name="Sacchi N."/>
<person name="Liu J.M."/>
<person name="Ross C.A."/>
</authorList>
<dbReference type="PubMed" id="10973986"/>
<dbReference type="DOI" id="10.1083/jcb.150.5.939"/>
</citation>
<scope>INTERACTION WITH MTG8</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Hum. Mol. Genet." volume="12" first="1535" last="1542">
<title>Dentatorubral-pallidoluysian atrophy protein is phosphorylated by c-Jun NH2-terminal kinase.</title>
<authorList>
<person name="Okamura-Oho Y."/>
<person name="Miyashita T."/>
<person name="Nagao K."/>
<person name="Shima S."/>
<person name="Ogata Y."/>
<person name="Katada T."/>
<person name="Nishina H."/>
<person name="Yamada M."/>
</authorList>
<dbReference type="PubMed" id="12812981"/>
<dbReference type="DOI" id="10.1093/hmg/ddg168"/>
</citation>
<scope>PHOSPHORYLATION AT SER-739</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="13047" last="13055">
<title>Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity.</title>
<authorList>
<person name="Nucifora F.C. Jr."/>
<person name="Ellerby L.M."/>
<person name="Wellington C.L."/>
<person name="Wood J.D."/>
<person name="Herring W.J."/>
<person name="Sawa A."/>
<person name="Hayden M.R."/>
<person name="Dawson V.L."/>
<person name="Dawson T.M."/>
<person name="Ross C.A."/>
</authorList>
<dbReference type="PubMed" id="12464607"/>
<dbReference type="DOI" id="10.1074/jbc.m211224200"/>
</citation>
<scope>PROTEOLYTIC PROCESSING</scope>
<scope>NUCLEAR LOCALIZATION SIGNAL</scope>
<scope>NUCLEAR EXPORT SIGNAL</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77; SER-79; SER-101; SER-103; SER-107; THR-653; SER-661; SER-746 AND SER-748</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="6955" last="6965">
<title>Atrophin proteins interact with the Fat1 cadherin and regulate migration and orientation in vascular smooth muscle cells.</title>
<authorList>
<person name="Hou R."/>
<person name="Sibinga N.E."/>
</authorList>
<dbReference type="PubMed" id="19131340"/>
<dbReference type="DOI" id="10.1074/jbc.m809333200"/>
</citation>
<scope>INTERACTION WITH FAT1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-641</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="FEBS J." volume="277" first="4873" last="4887">
<title>Proteolytic processing regulates pathological accumulation in dentatorubral-pallidoluysian atrophy.</title>
<authorList>
<person name="Suzuki Y."/>
<person name="Nakayama K."/>
<person name="Hashimoto N."/>
<person name="Yazawa I."/>
</authorList>
<dbReference type="PubMed" id="20977674"/>
<dbReference type="DOI" id="10.1111/j.1742-4658.2010.07893.x"/>
</citation>
<scope>PROTEOLYTIC PROCESSING</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="19391" last="19401">
<title>Y65C missense mutation in the WW domain of the Golabi-Ito-Hall syndrome protein PQBP1 affects its binding activity and deregulates pre-mRNA splicing.</title>
<authorList>
<person name="Tapia V.E."/>
<person name="Nicolaescu E."/>
<person name="McDonald C.B."/>
<person name="Musi V."/>
<person name="Oka T."/>
<person name="Inayoshi Y."/>
<person name="Satteson A.C."/>
<person name="Mazack V."/>
<person name="Humbert J."/>
<person name="Gaffney C.J."/>
<person name="Beullens M."/>
<person name="Schwartz C.E."/>
<person name="Landgraf C."/>
<person name="Volkmer R."/>
<person name="Pastore A."/>
<person name="Farooq A."/>
<person name="Bollen M."/>
<person name="Sudol M."/>
</authorList>
<dbReference type="PubMed" id="20410308"/>
<dbReference type="DOI" id="10.1074/jbc.m109.084525"/>
</citation>
<scope>INTERACTION WITH PQBP1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-34</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-661</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77; SER-632; SER-661; THR-669 AND SER-896</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-101</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1183</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2019" name="Am. J. Hum. Genet." volume="104" first="542" last="552">
<title>De novo variants disrupting the HX repeat motif of ATN1 cause a recognizable non-progressive neurocognitive syndrome.</title>
<authorList>
<person name="Palmer E.E."/>
<person name="Hong S."/>
<person name="Al Zahrani F."/>
<person name="Hashem M.O."/>
<person name="Aleisa F.A."/>
<person name="Ahmed H.M.J."/>
<person name="Kandula T."/>
<person name="Macintosh R."/>
<person name="Minoche A.E."/>
<person name="Puttick C."/>
<person name="Gayevskiy V."/>
<person name="Drew A.P."/>
<person name="Cowley M.J."/>
<person name="Dinger M."/>
<person name="Rosenfeld J.A."/>
<person name="Xiao R."/>
<person name="Cho M.T."/>
<person name="Yakubu S.F."/>
<person name="Henderson L.B."/>
<person name="Guillen Sacoto M.J."/>
<person name="Begtrup A."/>
<person name="Hamad M."/>
<person name="Shinawi M."/>
<person name="Andrews M.V."/>
<person name="Jones M.C."/>
<person name="Lindstrom K."/>
<person name="Bristol R.E."/>
<person name="Kayani S."/>
<person name="Snyder M."/>
<person name="Villanueva M.M."/>
<person name="Schteinschnaider A."/>
<person name="Faivre L."/>
<person name="Thauvin C."/>
<person name="Vitobello A."/>
<person name="Roscioli T."/>
<person name="Kirk E.P."/>
<person name="Bye A."/>
<person name="Merzaban J."/>
<person name="Jaremko L."/>
<person name="Jaremko M."/>
<person name="Sachdev R.K."/>
<person name="Alkuraya F.S."/>
<person name="Arold S.T."/>
</authorList>
<dbReference type="PubMed" id="30827498"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2019.01.013"/>
</citation>
<scope>INVOLVEMENT IN CHEDDA</scope>
<scope>VARIANTS CHEDDA ASN-1054; TYR-1058; 1059-SER-HIS-1060 DELINS ASN-LEU; 1059-SER-HIS-1060 DELINS ASP-LEU; TYR-1060; ARG-1062; ASP-1062 AND ARG-1063</scope>
<scope>CHARACTERIZATION OF VARIANT CHEDDA TYR-1060</scope>
<scope>REGION</scope>
</reference>
<comment type="function">
<text evidence="9 11 14">Transcriptional corepressor. Recruits NR2E1 to repress transcription. Promotes vascular smooth cell (VSMC) migration and orientation (By similarity). Corepressor of MTG8 transcriptional repression. Has some intrinsic repression activity which is independent of the number of poly-Gln (polyQ) repeats.</text>
</comment>
<comment type="subunit">
<text evidence="9 12 13 14 17 18 27">Interacts with NR2E1; the interaction represses the transcriptional activity of NR2E1. Interacts (via its N-terminus) with FAT1 (via a C-terminal domain) (By similarity). Interacts with BAIAP2, WWP1, WWP2, WWP3 and RERE. Interacts (via its N-terminus) with MTG8; the interaction enhances transcriptional repression of MTG8. Interacts with PQBP1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-945980">
<id>P54259</id>
</interactant>
<interactant intactId="EBI-536772">
<id>Q12805</id>
<label>EFEMP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-945980">
<id>P54259</id>
</interactant>
<interactant intactId="EBI-743414">
<id>O95967</id>
<label>EFEMP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-945980">
<id>P54259</id>
</interactant>
<interactant intactId="EBI-945934">
<id>Q9HAU0</id>
<label>PLEKHA5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-945980">
<id>P54259</id>
</interactant>
<interactant intactId="EBI-355546">
<id>P61289</id>
<label>PSME3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-945980">
<id>P54259</id>
</interactant>
<interactant intactId="EBI-945906">
<id>Q9NWB1</id>
<label>RBFOX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-945980">
<id>P54259</id>
</interactant>
<interactant intactId="EBI-948076">
<id>Q9P2R6</id>
<label>RERE</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-945980">
<id>P54259</id>
</interactant>
<interactant intactId="EBI-742327">
<id>Q15654</id>
<label>TRIP6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-945980">
<id>P54259</id>
</interactant>
<interactant intactId="EBI-540834">
<id>P61964</id>
<label>WDR5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Perinuclear region</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="10">Cell junction</location>
</subcellularLocation>
<text evidence="8">Shuttles between nucleus and cytoplasm. Colocalizes with FAT1 in the perinuclear area, at cell-cell junctions and leading edges of cells (By similarity). Colocalizes with MTG8 in discrete nuclear dots. Proteolytic fragment F1 appears to remain in nucleus. Fragment F2 is exported into the cytoplasm. Fragment F2 from mutant sequences with longer poly-Gln (polyQ) tracts are additionally located to the cytoplasmic membrane and to certain organelles.</text>
</comment>
<comment type="tissue specificity">
<text evidence="21 22 25">Widely expressed in various tissues including heart, lung, kidney, ovary, testis, prostate, placenta, skeletal Low levels in the liver, thymus and leukocytes. In the adult brain, broadly expressed in amygdala, caudate nucleus, corpus callosum, hippocampus, hypothalamus, substantia nigra, subthalamic nucleus, and thalamus. High levels in fetal tissues, especially brain.</text>
</comment>
<comment type="domain">
<text evidence="20">The HX repeat motif is a specific pH-dependent interaction motif for ions and/or proteins or other biomolecules. This motif could be involved in the control of embryonic development.</text>
</comment>
<comment type="PTM">
<text evidence="16">Phosphorylated in vitro by MAPK8/JNK1 on Ser-739. Mutant ATN1 sequences with expanded poly-Gln (polyQ) traits are more slowly phosphorylated.</text>
</comment>
<comment type="PTM">
<text evidence="11 15 19 26">Proteolytically cleaved, probably in the nucleus, to produce two C-terminal fragments of 140 kDa (F1) and 125 kDa (F2) each containing poly-Gln (polyQ) tracts. F2 is produced by cleavage by caspases and is exported into the cytoplasm. In vitro, cleavage increases with an increase in the number of polyQ tracts. C-terminal proteolytic products appear to be the cause of cell toxicity. In vitro cleavage at Asp-109.</text>
</comment>
<comment type="polymorphism">
<text evidence="23">The poly-Gln region of ATN1 is highly polymorphic (7 to 23 repeats) in the normal population and is expanded to about 49-75 repeats in DRPLA and HRS patients. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.</text>
</comment>
<comment type="disease" evidence="22 24">
<disease id="DI-01476">
<name>Dentatorubral-pallidoluysian atrophy</name>
<acronym>DRPLA</acronym>
<description>Autosomal dominant neurodegenerative disorder characterized by a loss of neurons in the dentate nucleus, rubrum, glogus pallidus and Luys'body. Clinical features are myoclonus epilepsy, dementia, and cerebellar ataxia. Onset of the disease occurs usually in the second decade of life and death in the fourth.</description>
<dbReference type="MIM" id="125370"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="20">
<disease id="DI-05610">
<name>Congenital hypotonia, epilepsy, developmental delay, and digital anomalies</name>
<acronym>CHEDDA</acronym>
<description>An autosomal dominant neurodevelopmental syndrome characterized by severe global developmental delay, impaired intellectual development, poor or absent language, significant motor disability with inability to walk, dysmorphic facial features, skeletal anomalies, and variable congenital malformations. Most patients also have seizures and structural brain abnormalities.</description>
<dbReference type="MIM" id="618494"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="sequence caution" evidence="28">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="BAA07534" version="1"/>
</conflict>
</comment>
<dbReference type="EMBL" id="D31840">
<property type="protein sequence ID" value="BAA06626.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D38529">
<property type="protein sequence ID" value="BAA07534.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U23851">
<property type="protein sequence ID" value="AAB50276.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U47924">
<property type="protein sequence ID" value="AAB51321.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="D63808">
<property type="protein sequence ID" value="BAA23631.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31734.1"/>
<dbReference type="PIR" id="G01763">
<property type="entry name" value="G01763"/>
</dbReference>
<dbReference type="PIR" id="S50832">
<property type="entry name" value="S50832"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001007027.1">
<property type="nucleotide sequence ID" value="NM_001007026.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001931.2">
<property type="nucleotide sequence ID" value="NM_001940.3"/>
</dbReference>
<dbReference type="SMR" id="P54259"/>
<dbReference type="BioGRID" id="108156">
<property type="interactions" value="129"/>
</dbReference>
<dbReference type="DIP" id="DIP-29423N"/>
<dbReference type="IntAct" id="P54259">
<property type="interactions" value="93"/>
</dbReference>
<dbReference type="MINT" id="P54259"/>
<dbReference type="STRING" id="9606.ENSP00000349076"/>
<dbReference type="iPTMnet" id="P54259"/>
<dbReference type="PhosphoSitePlus" id="P54259"/>
<dbReference type="BioMuta" id="ATN1"/>
<dbReference type="DMDM" id="317373480"/>
<dbReference type="EPD" id="P54259"/>
<dbReference type="jPOST" id="P54259"/>
<dbReference type="MassIVE" id="P54259"/>
<dbReference type="MaxQB" id="P54259"/>
<dbReference type="PaxDb" id="P54259"/>
<dbReference type="PeptideAtlas" id="P54259"/>
<dbReference type="PRIDE" id="P54259"/>
<dbReference type="ProteomicsDB" id="56663"/>
<dbReference type="Antibodypedia" id="22787">
<property type="antibodies" value="137 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="1822"/>
<dbReference type="Ensembl" id="ENST00000356654">
<property type="protein sequence ID" value="ENSP00000349076"/>
<property type="gene ID" value="ENSG00000111676"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000396684">
<property type="protein sequence ID" value="ENSP00000379915"/>
<property type="gene ID" value="ENSG00000111676"/>
</dbReference>
<dbReference type="GeneID" id="1822"/>
<dbReference type="KEGG" id="hsa:1822"/>
<dbReference type="UCSC" id="uc001qrw.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1822"/>
<dbReference type="DisGeNET" id="1822"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000111676.14"/>
<dbReference type="GeneCards" id="ATN1"/>
<dbReference type="GeneReviews" id="ATN1"/>
<dbReference type="HGNC" id="HGNC:3033">
<property type="gene designation" value="ATN1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000111676">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="ATN1"/>
<dbReference type="MIM" id="125370">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="607462">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="618494">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P54259"/>
<dbReference type="OpenTargets" id="ENSG00000111676"/>
<dbReference type="Orphanet" id="101">
<property type="disease" value="Dentatorubral pallidoluysian atrophy"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27487"/>
<dbReference type="eggNOG" id="KOG2133">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000153615"/>
<dbReference type="HOGENOM" id="CLU_005292_0_0_1"/>
<dbReference type="InParanoid" id="P54259"/>
<dbReference type="KO" id="K05626"/>
<dbReference type="OMA" id="HAYPGYA"/>
<dbReference type="OrthoDB" id="215918at2759"/>
<dbReference type="PhylomeDB" id="P54259"/>
<dbReference type="TreeFam" id="TF328554"/>
<dbReference type="PathwayCommons" id="P54259"/>
<dbReference type="Reactome" id="R-HSA-8943724">
<property type="pathway name" value="Regulation of PTEN gene transcription"/>
</dbReference>
<dbReference type="SIGNOR" id="P54259"/>
<dbReference type="BioGRID-ORCS" id="1822">
<property type="hits" value="8 hits in 874 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="ATN1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="ATN1"/>
<dbReference type="GenomeRNAi" id="1822"/>
<dbReference type="Pharos" id="P54259">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P54259"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="RNAct" id="P54259">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000111676">
<property type="expression patterns" value="Expressed in left lobe of thyroid gland and 190 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="P54259">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030054">
<property type="term" value="C:cell junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016363">
<property type="term" value="C:nuclear matrix"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001085">
<property type="term" value="F:RNA polymerase II transcription factor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003714">
<property type="term" value="F:transcription corepressor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007417">
<property type="term" value="P:central nervous system development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051402">
<property type="term" value="P:neuron apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR017993">
<property type="entry name" value="Atrophin-1"/>
</dbReference>
<dbReference type="InterPro" id="IPR002951">
<property type="entry name" value="Atrophin-like"/>
</dbReference>
<dbReference type="Pfam" id="PF03154">
<property type="entry name" value="Atrophin-1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PRINTS" id="PR01222">
<property type="entry name" value="ATROPHIN"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0818">Triplet repeat expansion</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Atrophin-1" id="PRO_0000064730">
<location>
<begin position="1"/>
<end position="1190"/>
</location>
</feature>
<feature type="region of interest" description="Involved in binding BAIAP2">
<location>
<begin position="517"/>
<end position="567"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with FAT1" evidence="17">
<location>
<begin position="879"/>
<end position="894"/>
</location>
</feature>
<feature type="region of interest" description="HX repeat" evidence="20">
<location>
<begin position="1049"/>
<end position="1065"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="15">
<location>
<begin position="16"/>
<end position="32"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal">
<location>
<begin position="1033"/>
<end position="1041"/>
</location>
</feature>
<feature type="compositionally biased region" description="Glu/Ser-rich">
<location>
<begin position="73"/>
<end position="82"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="302"/>
<end position="305"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="376"/>
<end position="382"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="386"/>
<end position="397"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="442"/>
<end position="447"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-His">
<location>
<begin position="479"/>
<end position="483"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="484"/>
<end position="502"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="509"/>
<end position="512"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="569"/>
<end position="579"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="709"/>
<end position="712"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ala/Arg-rich">
<location>
<begin position="807"/>
<end position="820"/>
</location>
</feature>
<feature type="compositionally biased region" description="Arg/Glu-rich (mixed charge)">
<location>
<begin position="821"/>
<end position="832"/>
</location>
</feature>
<feature type="compositionally biased region" description="Arg/Glu-rich (mixed charge)">
<location>
<begin position="930"/>
<end position="939"/>
</location>
</feature>
<feature type="site" description="Cleavage; by CASP-3" evidence="11 26">
<location>
<begin position="109"/>
<end position="110"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="34"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 5">
<location>
<position position="77"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="79"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 6">
<location>
<position position="101"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="103"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="107"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="632"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="2">
<location>
<position position="641"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="1">
<location>
<position position="653"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 4 5">
<location>
<position position="661"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5">
<location>
<position position="669"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK8" evidence="16">
<location>
<position position="739"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="746"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="748"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="896"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="9">
<location>
<position position="1115"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="7">
<location>
<position position="1183"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1058045." id="VAR_030937" evidence="25">
<original>M</original>
<variation>I</variation>
<location>
<position position="339"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_064038" evidence="21 22 25">
<location>
<begin position="484"/>
<end position="488"/>
</location>
</feature>
<feature type="sequence variant" description="In CHEDDA." id="VAR_083058" evidence="20">
<original>H</original>
<variation>N</variation>
<location>
<position position="1054"/>
</location>
</feature>
<feature type="sequence variant" description="In CHEDDA." id="VAR_083059" evidence="20">
<original>H</original>
<variation>Y</variation>
<location>
<position position="1058"/>
</location>
</feature>
<feature type="sequence variant" description="In CHEDDA; unknown pathological significance." id="VAR_083060" evidence="20">
<original>SH</original>
<variation>DL</variation>
<location>
<begin position="1059"/>
<end position="1060"/>
</location>
</feature>
<feature type="sequence variant" description="In CHEDDA; unknown pathological significance." id="VAR_083061" evidence="20">
<original>SH</original>
<variation>NL</variation>
<location>
<begin position="1059"/>
<end position="1060"/>
</location>
</feature>
<feature type="sequence variant" description="In CHEDDA; the mutation resulted in a perturbation of the structural and functional integrity of the HX repeat; altered zinc-binding properties of the HX repeat." id="VAR_083062" evidence="20">
<original>H</original>
<variation>Y</variation>
<location>
<position position="1060"/>
</location>
</feature>
<feature type="sequence variant" description="In CHEDDA." id="VAR_083063" evidence="20">
<original>H</original>
<variation>D</variation>
<location>
<position position="1062"/>
</location>
</feature>
<feature type="sequence variant" description="In CHEDDA." id="VAR_083064" evidence="20">
<original>H</original>
<variation>R</variation>
<location>
<position position="1062"/>
</location>
</feature>
<feature type="sequence variant" description="In CHEDDA." id="VAR_083065" evidence="20">
<original>L</original>
<variation>R</variation>
<location>
<position position="1063"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents cleavage and suppresses apoptosis." evidence="11">
<original>D</original>
<variation>N</variation>
<location>
<position position="109"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation.">
<original>S</original>
<variation>A</variation>
<location>
<position position="739"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAB50276." ref="3" evidence="28">
<location>
<position position="94"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAA06626." ref="1" evidence="28">
<original>H</original>
<variation>Y</variation>
<location>
<position position="333"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAA06626." ref="1" evidence="28">
<original>A</original>
<variation>G</variation>
<location>
<position position="1033"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250"/>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O35126"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P54258"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10085113"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10332026"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10814707"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10973986"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12464607"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12812981"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19131340"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20410308"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20977674"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30827498"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7485154"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7842016"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7951323"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8136840"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8965642"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9361003"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9647693"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000305"/>
<sequence length="1190" mass="125414" checksum="B47603486C672637" modified="2011-01-11" version="3">MKTRQNKDSMSMRSGRKKEAPGPREELRSRGRASPGGVSTSSSDGKAEKSRQTAKKARVEEASTPKVNKQGRSEEISESESEETNAPKKTKTEQELPRPQSPSDLDSLDGRSLNDDGSSDPRDIDQDNRSTSPSIYSPGSVENDSDSSSGLSQGPARPYHPPPLFPPSPQPPDSTPRQPEASFEPHPSVTPTGYHAPMEPPTSRMFQAPPGAPPPHPQLYPGGTGGVLSGPPMGPKGGGAASSVGGPNGGKQHPPPTTPISVSSSGASGAPPTKPPTTPVGGGNLPSAPPPANFPHVTPNLPPPPALRPLNNASASPPGLGAQPLPGHLPSPHAMGQGMGGLPPGPEKGPTLAPSPHSLPPASSSAPAPPMRFPYSSSSSSSAAASSSSSSSSSSASPFPASQALPSYPHSFPPPTSLSVSNQPPKYTQPSLPSQAVWSQGPPPPPPYGRLLANSNAHPGPFPPSTGAQSTAHPPVSTHHHHHQQQQQQQQQQQQQQQQQQQHHGNSGPPPPGAFPHPLEGGSSHHAHPYAMSPSLGSLRPYPPGPAHLPPPHSQVSYSQAGPNGPPVSSSSNSSSSTSQGSYPCSHPSPSQGPQGAPYPFPPVPTVTTSSATLSTVIATVASSPAGYKTASPPGPPPYGKRAPSPGAYKTATPPGYKPGSPPSFRTGTPPGYRGTSPPAGPGTFKPGSPTVGPGPLPPAGPSGLPSLPPPPAAPASGPPLSATQIKQEPAEEYETPESPVPPARSPSPPPKVVDVPSHASQSARFNKHLDRGFNSCARSDLYFVPLEGSKLAKKRADLVEKVRREAEQRAREEKEREREREREKEREREKERELERSVKLAQEGRAPVECPSLGPVPHRPPFEPGSAVATVPPYLGPDTPALRTLSEYARPHVMSPGNRNHPFYVPLGAVDPGLLGYNVPALYSSDPAAREREREARERDLRDRLKPGFEVKPSELEPLHGVPGPGLDPFPRHGGLALQPGPPGLHPFPFHPSLGPLERERLALAAGPALRPDMSYAERLAAERQHAERVAALGNDPLARLQMLNVTPHHHQHSHIHSHLHLHQQDAIHAASASVHPLIDPLASGSHLTRIPYPAGTLPNPLLPHPLHENEVLRHQLFAAPYRDLPASLSAPMSAAHQLQAMHAQSAELQRLALEQQQWLHAHHPLHSVPLPAQEDYYSHLKKESDKPL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

